insights_auto
Outlook: 82.3% bullish·5.9% bearish
Go to analysischevron_right
TGTX:NASDAQ
TG Therapeutics Inc common stock
$64.56
arrow_downward
-1.82%(-1.20) 1D
$64.21
arrow_downward
-0.55% (-0.35)bedtimeAfter hours
Closed: Nov 12, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TGTX...
Open
$65.76
High
$65.86
Low
$63.28
Mkt. cap
9.76B
Avg. vol.
1.95M
Volume
39.00
P/E ratio
95.89
52-wk high
$68.03
52-wk low
$26.76
EPS
$0.67
Beta
1.89
Shares outstanding
151.15M
No. of employees
399
Open
$65.76
High
$65.86
Low
$63.28
Mkt. cap
9.76B
Avg. vol.
1.95M
Volume
39.00
P/E ratio
95.89
52-wk high
$68.03
52-wk low
$26.76
EPS
$0.67
Beta
1.89
Shares outstanding
151.15M
No. of employees
399
News stories
From web sources and news partners
Yahoo! Finance Canada
·
2 days ago
TG Therapeutics (TGTX) Lifts Revenue Guidance As Investors Ask If The Stock Is Pricey
Yahoo Finance
·
2 days ago
TG Therapeutics (TGTX) Stock Stays Hard To Justify Despite Raised Revenue Guidance
Investor's Business Daily
·
2 days ago
How Stock Of The Day TG Therapeutics Is Making Waves For Its Rivals
About TG Therapeutics Inc common stock
CEOMichael S Weiss
Employees399
Founded1993
HeadquartersMorrisville, North Carolina, United States
SectorHealth Care
IndustryBiotechnology
Websitetgtherapeutics.com